Amdocs(DOX) - 2024 Q1 - Quarterly Report

Fiscal 2023 Performance Overview Amdocs achieved record fiscal year 2023 performance with significant revenue growth, increased non-GAAP diluted EPS, strong free cash flow, and a record twelve-month backlog, driven by modernization projects and cloud activities Full Year Fiscal 2023 Highlights For the full fiscal year 2023, Amdocs achieved record revenue of $4.89 billion, marking a 6.8% year-over-year increase as reported and 7.7% in constant currency. Non-GAAP diluted EPS grew by 11.5% to $5.91, accompanied by strong free cash flow of $698 million and a record twelve-month backlog of $4.15 billion Fiscal Year 2023 Key Financial Metrics | Metric | Value | YoY Growth | | :--- | :--- | :--- | | Revenue | $4,888 million | 6.8% | | Revenue (Constant Currency) | - | 7.7% | | GAAP Diluted EPS | $4.49 | 1.1% | | Non-GAAP Diluted EPS | $5.91 | 11.5% | | Free Cash Flow | $698 million | - | | Share Repurchases | $490 million | - | | 12-Month Backlog | $4.15 billion | 4.5% | - The company reported record performance in key segments and regions, including: - Record managed services revenue of $2,857 million, constituting approximately 58% of total revenue - Record revenue from North America ($3,307 million) and Europe ($703 million)[2] Fourth Quarter Fiscal 2023 Highlights In the fourth quarter of fiscal 2023, Amdocs posted record revenue of $1.24 billion, a 6.5% year-over-year increase, exceeding the midpoint of guidance. Non-GAAP diluted EPS was $1.42, also above the guidance midpoint. The company announced a 10% increase in its quarterly cash dividend and a change in the Chairman of the Board Q4 Fiscal 2023 Key Financial Metrics | Metric | Value | YoY Change | Guidance | | :--- | :--- | :--- | :--- | | Revenue | $1,243 million | +6.5% | $1,220 - $1,260M | | GAAP Diluted EPS | $0.86 | - | $0.67 - $0.81 | | Non-GAAP Diluted EPS | $1.42 | - | $1.38 - $1.44 | | GAAP Operating Margin | 11.2% | -350 bps | - | | Non-GAAP Operating Margin | 17.8% | +20 bps | - | - The Board of Directors approved a 10% increase in the quarterly cash dividend from $0.435 to $0.479 per share, expected to be first paid in April 2024, subject to shareholder approval[4] - Effective November 7, 2023, Mr. Eli Gelman was appointed as the new Chairman of the Board, succeeding Mr. Rob Minicucci, who stepped down but remains a director[4] Management Commentary Management attributed the strong fiscal 2023 performance to supporting customers' multi-year modernization journeys, including digital transformation, cloud migration, and 5G monetization. Cloud activities revenue grew at a double-digit rate, exceeding 20% of total revenue. Looking ahead to fiscal 2024, the company expects continued growth driven by modernization projects and accelerated profitability, despite headwinds from reduced spending on legacy systems - Growth in FY2023 was driven by supporting customers' digital modernization, network automation, cloud migration, and the deployment of 5G and fiber networks[5] - Revenue from cloud activities grew at a double-digit rate in fiscal 2023, surpassing 20% of total revenue for the first time[5] - The company is advancing its Generative-AI leadership by embedding telco-specific use cases across its CES suite, leveraging its Microsoft partnership and Amdocs amAIz framework[5] - For fiscal 2024, revenue growth is expected to be impacted by service providers prioritizing modernization programs over investments in legacy systems, but the company still anticipates double-digit cloud revenue growth and accelerated profitability improvement[7][8] Financial Results Amdocs reported strong financial results for fiscal year 2023 and Q4, with significant revenue growth, increased non-GAAP diluted EPS, strategic capital allocation through acquisitions and shareholder returns, and a record twelve-month backlog Revenue For the fourth quarter of fiscal 2023, revenue was $1.243 billion, a 6.5% increase as reported. For the full fiscal year, revenue reached $4.888 billion, up 6.8% as reported and 7.7% on a constant currency basis. Both quarterly and full-year results were within or above guidance ranges Q4 & Full Year Fiscal 2023 Revenue Performance | Period | Revenue (in millions) | YoY Growth (As Reported) | YoY Growth (Constant Currency) | | :--- | :--- | :--- | :--- | | Q4 2023 | $1,243 | 6.5% | 6.3% | | FY 2023 | $4,888 | 6.8% | 7.7% | - Foreign currency movements had an unfavorable impact of approximately $2 million in Q4 2023 relative to Q3 2023, and an unfavorable impact of approximately 0.9% for the full fiscal year 2023[8] Net Income and Earnings Per Share For fiscal year 2023, GAAP diluted EPS was $4.49, while Non-GAAP diluted EPS was $5.91, an 11.5% increase year-over-year. In the fourth quarter, GAAP diluted EPS was $0.86, and Non-GAAP diluted EPS was $1.42. The difference between GAAP and Non-GAAP figures is primarily due to restructuring charges, amortization of intangibles, and equity-based compensation FY 2023 vs FY 2022 Earnings Per Share | Metric | FY 2023 | FY 2022 | YoY Change | | :--- | :--- | :--- | :--- | | GAAP Net Income (attributable) | $540.7M | $549.5M | -1.6% | | GAAP Diluted EPS | $4.49 | $4.44 | +1.1% | | Non-GAAP Net Income (attributable) | $712.2M | $655.1M | +8.7% | | Non-GAAP Diluted EPS | $5.91 | $5.30 | +11.5% | Q4 2023 vs Q4 2022 Earnings Per Share | Metric | Q4 2023 | Q4 2022 | | :--- | :--- | :--- | | GAAP Diluted EPS | $0.86 | $1.05 | | Non-GAAP Diluted EPS | $1.42 | $1.29 | Capital Allocation Amdocs actively managed its capital through acquisitions, dividends, and share repurchases. The company completed the acquisition of Procom Consulting and Astadia. It also announced a 10% dividend increase and repurchased $155 million of its shares in the fourth quarter - M&A Activity: - Completed the acquisition of Procom Consulting for ~$37 million - Completed the acquisition of Astadia for ~$75 million in cash[10] - Shareholder Returns: - The Board approved a 10% increase in the quarterly cash dividend to $0.479 per share, effective April 2024 - Repurchased $155 million of ordinary shares during Q4 fiscal 2023[10] Twelve-month Backlog The company's twelve-month backlog reached a record $4.15 billion at the end of the fourth quarter of fiscal 2023. This represents a 4.5% increase compared to the same period last year, indicating solid future revenue visibility - The twelve-month backlog was a record $4.15 billion at the end of Q4 2023[11] - This represents an increase of approximately 4.5% compared to the fourth fiscal quarter of the prior year[11] Fiscal 2024 Outlook Amdocs provides its financial outlook for fiscal year 2024, projecting continued revenue and EPS growth, along with strong free cash flow, while considering ongoing macroeconomic and geopolitical risks First Quarter Fiscal 2024 Outlook For the first quarter of fiscal 2024, Amdocs projects revenue to be between $1.225 billion and $1.265 billion. GAAP diluted EPS is expected to be in the range of $1.18 to $1.26, with Non-GAAP diluted EPS projected between $1.53 and $1.59 Q1 Fiscal 2024 Guidance | Metric | Guidance Range | | :--- | :--- | | Revenue | $1,225M - $1,265M | | GAAP Diluted EPS | $1.18 - $1.26 | | Non-GAAP Diluted EPS | $1.53 - $1.59 | Full Year Fiscal 2024 Outlook Amdocs anticipates revenue growth of 1.0% to 5.0% for the full fiscal year 2024. The company expects strong double-digit growth in GAAP diluted EPS (11.0% to 18.0%) and high single-to-low double-digit growth in Non-GAAP diluted EPS (8.0% to 12.0%). Free cash flow is projected to be approximately $750 million Full Year Fiscal 2024 Guidance | Metric | YoY Growth Guidance | | :--- | :--- | | Revenue Growth (As Reported) | 1.0% - 5.0% | | Revenue Growth (Constant Currency) | 1.2% - 5.2% | | GAAP Diluted EPS Growth | 11.0% - 18.0% | | Non-GAAP Diluted EPS Growth | 8.0% - 12.0% | | Free Cash Flow | ~$750 million | - The company anticipates Non-GAAP operating margin to be within a range of 18.1% to 18.7% for the full year[16] - The outlook considers ongoing macroeconomic and geopolitical risks, including the conflict in Israel and the inflationary environment[15] Financial Statements The financial statements provide a detailed overview of Amdocs' fiscal year 2023 performance, including consolidated statements of income, balance sheets, and cash flows, alongside supplementary geographical and backlog data Consolidated Statements of Income For the fiscal year ended September 30, 2023, Amdocs reported total revenues of $4.888 billion, up from $4.577 billion in 2022. Operating income was $654 million, slightly down from $665 million in the prior year, primarily due to $70.9 million in restructuring charges. Net income attributable to Amdocs Limited was $540.7 million Fiscal Year 2023 Income Statement Highlights (in thousands) | Line Item | FY 2023 | FY 2022 | | :--- | :--- | :--- | | Revenue | $4,887,550 | $4,576,697 | | Total Operating Expenses | $4,233,560 | $3,911,900 | | Operating Income | $653,990 | $664,797 | | Income Before Income Taxes | $636,361 | $648,406 | | Net Income Attributable to Amdocs | $540,709 | $549,501 | Condensed Consolidated Balance Sheets As of September 30, 2023, Amdocs had total assets of $6.43 billion, a slight increase from $6.39 billion in the prior year. Cash and short-term investments stood at $742.5 million. Total shareholders' equity increased marginally to $3.52 billion Balance Sheet Highlights (as of Sep 30, in thousands) | Account | 2023 | 2022 | | :--- | :--- | :--- | | Assets | | | | Cash & Short-term Investments | $742,531 | $817,980 | | Total Current Assets | $1,911,630 | $2,003,147 | | Goodwill and other intangible assets, net | $2,930,580 | $2,841,137 | | Total Assets | $6,425,653 | $6,390,393 | | Liabilities & Equity | | | | Total Current Liabilities | $1,353,375 | $1,252,680 | | Long-term Debt, net | $645,696 | $645,117 | | Total Amdocs Limited Shareholders' Equity | $3,523,759 | $3,517,769 | | Total Liabilities and Equity | $6,425,653 | $6,390,393 | Consolidated Statements of Cash Flows For fiscal year 2023, net cash provided by operating activities was $822.6 million. After accounting for investing and financing activities, including $489.5 million in share repurchases and $199.5 million in dividend payments, the company saw a net decrease in cash and cash equivalents of $53.3 million Fiscal Year 2023 Cash Flow Summary (in thousands) | Activity | FY 2023 | FY 2022 | | :--- | :--- | :--- | | Net Cash Provided by Operating Activities | $822,630 | $756,719 | | Net Cash Used in Investing Activities | ($224,497) | ($262,501) | | Net Cash Used in Financing Activities | ($651,430) | ($629,905) | | Net Decrease in Cash | ($53,297) | ($135,687) | | Cash at End of Year | $520,080 | $573,377 | Supplementary Financial Information Revenue from North America remained the largest contributor, showing consistent sequential growth throughout fiscal 2023. Managed services revenue was relatively stable quarterly, totaling $2.857 billion for the year. The 12-month backlog demonstrated steady sequential growth, ending the year at a record $4.15 billion Quarterly Revenue by Geography (in millions) | Region | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | | :--- | :--- | :--- | :--- | :--- | :--- | | North America | $834.4 | $830.9 | $829.0 | $812.7 | $794.4 | | Europe | $175.5 | $187.3 | $171.7 | $168.7 | $146.4 | | Rest of the World | $232.6 | $217.8 | $222.6 | $204.3 | $225.7 | | Total Revenue | $1,242.6 | $1,236.0 | $1,223.3 | $1,185.7 | $1,166.5 | 12-Month Backlog Trend (in millions) | As of | Backlog | | :--- | :--- | | Sep 30, 2023 | $4,150 | | Jun 30, 2023 | $4,140 | | Mar 31, 2023 | $4,110 | | Dec 31, 2022 | $4,090 | | Sep 30, 2022 | $3,970 | Non-GAAP Financial Measures and Reconciliations This section explains the company's use of non-GAAP financial measures, detailing the adjustments made to GAAP results and providing comprehensive reconciliations for enhanced financial analysis Explanation of Non-GAAP Measures Amdocs uses non-GAAP financial measures to provide investors with additional insight into its financial and business trends. These measures exclude items such as amortization of purchased intangibles, restructuring charges, equity-based compensation, and related tax effects. Management uses these adjusted figures for internal budgeting and performance monitoring - Non-GAAP measures exclude specific items to provide a clearer view of operational performance. Key exclusions include: - Amortization of purchased intangible assets - Restructuring charges - Equity-based compensation expense - Changes in certain acquisition-related liabilities[19] - The company believes these measures are useful for investors as they align with how management evaluates the business and are often used by peers for comparison[21][22] GAAP to Non-GAAP Reconciliation The report provides detailed tables reconciling GAAP results to non-GAAP results for both the fourth quarter and the full fiscal years 2023 and 2022. For fiscal year 2023, the largest adjustments to operating income were for equity-based compensation ($89.7 million), restructuring charges ($70.9 million), and amortization of purchased intangibles ($57.2 million) FY 2023 GAAP to Non-GAAP Operating Income Reconciliation (in thousands) | Description | Amount | | :--- | :--- | | GAAP Operating Income | $653,990 | | Amortization of purchased intangible assets | $57,156 | | Equity-based compensation expense | $89,698 | | Changes in certain acquisition liabilities | ($3,143) | | Restructuring charges | $70,901 | | Non-GAAP Operating Income | $868,602 |